Aben Gold Provides Drill Program Update at Justin Gold-Tungsten Project

Vancouver, BC, Sept. 01, 2026 (GLOBE NEWSWIRE) — Aben Gold Corp. (TSX-V: ABM) (OTCID: ABNAF) (Frankfurt: ML1) (“Aben” or “the Company”) is pleased to provide an update on the fully funded 2026 diamond drill program at its 100%-owned Justin Gold-Tungsten Project in southeastern Yukon Territory, approximately 25 kilometres from the past-producing Cantung Mine.

As of the August 30, 2026, daily field report, the Company has completed 766 metres of diamond drilling over 21 operating days, averaging 35.0 metres per day. A total of 785 core samples has been collected to date. The 2026 program is planned for approximately 1,300 metres.  Visual massive sulphides and ultraviolet indication of WO3. – see image 1 and 2.

First Hole Cut and Sent for Assay

Cutting of hole JN26-001 has been completed. The 341 samples from JN26-001 were dispatched on August 26, 2026, and submitted to Bureau Veritas for assay. Samples from JN26-002 (227 samples) and JN26-003 (217 samples) are being prepared for a subsequent dispatch.

eSUN Marks 24th Anniversary With Website Upgrade and September 3D Printing Sale

Wuhan, China, Sept. 01, 2026 (GLOBE NEWSWIRE) — eSUN is celebrating its 24th anniversary under the theme “Print the World, AI Powers Every Creation.” Alongside giving back to its global community, eSUN is also launching its newly upgraded official website, creating a more unified platform and a more professional service experience for makers worldwide.
In 2026, eSUN celebrates its 24th anniversary.

eSUN Marks 24th Anniversary With Website Upgrade and September 3D Printing Sale

Wuhan, China, Sept. 01, 2026 (GLOBE NEWSWIRE) — eSUN is celebrating its 24th anniversary under the theme “Print the World, AI Powers Every Creation.” Alongside giving back to its global community, eSUN is also launching its newly upgraded official website, creating a more unified platform and a more professional service experience for makers worldwide.
In 2026, eSUN celebrates its 24th anniversary.

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®

Together with the previously announced Talicia strategic divestiture, the acquisition from Ferring of commercialization rights to two larger, proprietary, established gastrointestinal (GI) FDA-approved drugs that together generated approximately $37.5 million in 2025 net sales, completes a major strategic repositioning of RedHill’s commercial GI business

Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

Dallas, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) — – Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced today that it has entered into a binding offer to acquire eCential Robotics, a leading developer of enabling technologies and surgical robotics. The acquisition expands the ASTRA™ enabling technology platform with robotic automation capabilities, creating a more comprehensive ecosystem designed to improve surgical precision, streamline workflows, and enhance patient outcomes. 

Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) —

Stryker (NYSE:SYK), a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and developer of the FiberLocker® System. This commercialized technology provides a novel approach for rotator cuff augmentation with increased biomechanical strength to address a key clinical failure mode in rotator cuff repair.

Gold-Standard Cochrane Review Confirms: Nicotine Vaping Helps More Smokers Quit Than Traditional Nicotine Replacement Therapy

The Canadian Vaping Association calls on Health Canada to align with the world’s most rigorous scientific evidence and better inform smokers that vaping is a less harmful alternative that can help them quit

The Canadian Vaping Association calls on Health Canada to align with the world's most rigorous scientific evidence and better inform smokers that vaping is a less harmful alternative that can help them quit